The survival and prognosis of three common treatments for prostate carcinoma and the factors impacting on them
- VernacularTitle:前列腺癌3种常用治疗方法的生存和预后分析及影响因素
- Author:
Jie CHEN
;
Danfeng XU
;
Yi GAO
;
Jizhong REN
;
Yacheng YAO
;
Yushan LIU
;
Xingang CUI
;
Jianping CHE
- Publication Type:Journal Article
- Keywords:
prostatic neoplasms;
therapeutic;
survival rate;
prognosis
- From:
China Oncology
2009;19(7):512-516
- CountryChina
- Language:Chinese
-
Abstract:
Background and purpose: The prognostic factors on survival for the patients with prostate carcinoma are still underdeterrnined. This study was to analyze the survival of three common treatment methods for prostate carcinoma and the prognostic factors on survival. Methods: 494 male patients who were diagnosed as prostate cancer were enrolled into the retrospective study. All of the data like age, stage, grade, PSA level, ALP, Hb and treatments were collected. Overall survival and disease specific survival rates for patients were analyzed by Kaplan-Meier method. Prognostic factors on disease specific survival were also analyzed by Log-rank test and Cox proportional hazards model. Results: Disease specific survival rates at 1, 3 and 5 year were 96.0%, 89.0% and 80.0% for all 494 patients, respectively. Disease specific survival rate at 3-year was 92.4% for brachytherapy, 100.0% for radical prostatectomy and 80.6% for hormonal therapy (P=0.008). Multivariate analysis by Cox model showed that stage, PSA level and age significantly impacted on disease specific survival. Conclusion: Brachytherapy and radical prostatectomy provides longer survival time than hormonal therapy for patients with prostate cancer. Clinical stage and PSA level and age of prostate cancer are independent factors impacting on survival significantly.
